A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: eternally (1)

DVd Weekly Daratumumab-Bortezomib-Dexamethasone Cycles 1 to 8

Description
Chemotherapy Protocol Myeloma DVd (Weekly) Bortezomib-Daratumumab-Dexamethasone (cycles 1 to 8) Regimen • Myeloma – Bortezomib (weekly)-Daratumumab-Dexamethas
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DVd-Weekly-Daratumumab-Bortezomib-Dexamethasone-Cycles-1-to-8.pdf

Isatuximab VRD weekly

Description
Chemotherapy Protocol Myeloma Isa-VRD weekly Isatuximab-Lenalidomide-Bortezomib-Dexamethasone (20) Regimen Myeloma – Isa-VRD weekly Isatuximab-Lenalidomide-Bortez
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Isatuximab-VRD-weekly-Ver1.pdf

DRD Daratumumab-Lenalidomide-Dexamethasone

Description
Chemotherapy Protocol Myeloma DRD Daratumumab-Lenalidomide-Dexamethasone Regimen • Myeloma – DRD Daratumumab-Lenalidomide-Dexamethasone Indica
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/DRD-Daratumumab-Lenalidomide-Dexamethasone.pdf

Urgent treatment for a heart attack - information for families

Description
Patient information factsheet Urgent treatment for a heart attack Information for relatives and friend
Url
/Media/UHS-website-2019/Patientinformation/Heartandlungs/Urgent-treatment-for-a-heart-attack-2551-PIL.pdf

ACCORD-2 example sub-protocol

Description
CONFIDENTIAL ACCORD-2-002 - Sub protocol for Bemcentinib (Amendment 01) TITLE PAGE Master Protocol Title: ACCORD-2: A Multicentre, Seamless, Phase 2 Adaptive Randomisation Platform
Url
/Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-example-sub-protocol.pdf

Deceiving patients

Description
Can deception ever be justified?
Url
/HealthProfessionals/Clinical-law-updates/Deceiving-patients.aspx

Acute kidney injury - patient information

Description
We have written this factsheet to provide you with information about acute kidney injury (AKI).
Url
/Media/UHS-website-2019/Patientinformation/Generalmedicine/Acute-kidney-injury-1090-PIL.pdf

Rituximab (weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (weekly) Regimen Lymphoma – Rituximab (weekly) Indication CD20 positive indolent non Hodgkin’s lym
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-weekly.pdf

Rituximab (3 weekly)

Description
Chemotherapy Protocol LYMPHOMA RITUXIMAB (3 Weekly) Regimen Lymphoma – Rituximab (3 weekly) Indication Non Hodgkin’s Lymphoma in combinatio
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-3-weekly.pdf

HSCTRituximab_100mg-7day

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT ALLOGRAFT RITUXIMAB 100mg (Weekly) Regimen • HSCT Allograft - Rituximab (7 day-100mg) Indications
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCTRituximab-100mg-7day.pdf
111 to 120 of 220
Previous … 10 11 12 13 14 … Next